Streetbeat News

Price Targets

MAXN

Goldman Sachs analyst Brian Lee maintains a Buy rating on Maxeon Solar Technologies (NASDAQ:MAXN) but has lowered the price target from $43 to $37.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:20 pm

ONTX

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Onconova Therapeutics (NASDAQ:ONTX) and maintained a price target of $11.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:19 pm

GDRX

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on GoodRx Holdings (NASDAQ:GDRX) and raised the price target from $6.25 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:19 pm

RCKT

Canaccord Genuity analyst Whitney Ijem maintains a Buy rating on Rocket Pharmaceuticals (NASDAQ:RCKT) but lowers the price target from $49 to $47.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 12:18 pm

CIB

Goldman Sachs analyst Tito Labarta maintains a Buy rating on BanColombia (NYSE:CIB) but lowers the price target from $39 to $35.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:17 pm

GBTG

Credit Suisse analyst Stephen Ju has maintained an 'Outperform' rating on Global Business Travel (NYSE:GBTG) and raised the price target from $10 to $12.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 12:16 pm

APP

Goldman Sachs analyst Eric Sheridan maintains a Buy rating on AppLovin (NASDAQ:APP) and raises the price target from $25 to $50.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:16 pm

STKL

Canaccord Genuity analyst Bobby Burleson has maintained a 'Buy' rating on SunOpta (NASDAQ:STKL) but lowered the price target from $14 to $8.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 12:14 pm

TGT

Barclays analyst Seth Sigman has maintained an Equal-Weight rating on Target (NYSE:TGT) and lowered the price target from $163 to $142.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:12 pm

CYBN

Canaccord Genuity analyst Sumant Kulkarni has maintained a 'Buy' rating on Cybin (AMEX:CYBN) but lowered the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:11 pm